Viewing nowCombinationLosanin Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 200608255 · Notified 2006.08.31 · Insurance code 649800570
Treatment of hypertension not controlled with monotherapy
This medication is used to effectively control blood pressure in hypertensive patients whose blood pressure is not sufficiently controlled with monotherapy.
○ Adults The usual dose is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs about 3 weeks after starting treatment. This drug may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this drug when monotherapy has not produced the expected effect. 1. Substitution therapy: Treatment with the individually titrated combination of losartan potassium and hydrochlorothiazide may be replaced with this drug. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who develop hypokalemia even though their blood pressure is controlled at this dose: Treatment may be started with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Continue to monitor the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg; if blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Use the usual dose if creatinine clearance is 30 mL/min or greater. Use of this drug is not recommended in patients with more severe renal impairment, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Use of this drug is not recommended in patients with hepatic impairment requiring dose adjustment, because this drug cannot provide the initial dose of losartan potassium, 25 mg, for such patients.
Children (under 18 years of age): As there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be administered to certain patients, such as those who are allergic to this drug or its components, have severe renal impairment, liver disorders, are pregnant, or have specific electrolyte disturbances. Patients with hypotension or renal function issues should use this medication with extra caution, as blood pressure may drop too low or renal function may worsen, requiring regular monitoring. This medication may alter potassium levels in the blood, so expert consultation is necessary if taken with potassium supplements or other medications containing potassium. Due to the hydrochlorothiazide component, electrolyte imbalance may occur, and it is important to regularly monitor electrolyte status through blood tests. Dizziness or drowsiness may occur during treatment, so caution is needed when driving or operating machinery. Additionally, exposure to sunlight while taking this medication may increase the risk of skin cancer, so regular use of sunscreen and skin examinations are recommended. If any unusual symptoms or side effects occur during use, immediate consultation with healthcare professionals is necessary, especially if blood pressure drops too low or severe allergic reactions, skin rashes, or breathing difficulties arise, which require immediate action. This medication is not recommended for use in children or adolescents due to insufficient experience in this population. Finally, this medication should be stored in its original container and kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a light-protective, tightly closed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius, avoiding extremely hot or cold environments.
Pale yellow, oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 30 tablets/PTP (for export)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.